Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Total 13F shares
-
28,186,736
-
Share change
-
+1,638,686
-
Total reported value
-
$234,808,696
-
Price per share
-
$8.33
-
Number of holders
-
98
-
Value change
-
+$16,433,326
-
Number of buys
-
57
-
Number of sells
-
37
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2021
As of 30 Jun 2021,
HARVARD BIOSCIENCE INC - Common Stock (HBIO) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,186,736 shares.
The largest 10 holders included
BlackRock Inc., ROYCE & ASSOCIATES LP, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, Portolan Capital Management, LLC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., GRANAHAN INVESTMENT MANAGEMENT INC/MA, RENAISSANCE TECHNOLOGIES LLC, Harvey Partners, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.